Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Equity (2016 - 2025)

Historic Return on Equity for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 2.7%.

  • Ptc Therapeutics' Return on Equity fell 32300.0% to 2.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.7%, marking a year-over-year decrease of 32300.0%. This contributed to the annual value of 0.65% for FY2024, which is 5700.0% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Return on Equity stood at 2.7%, which was down 32300.0% from 1.87% recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Return on Equity high stood at 11.71% for Q1 2022, and its period low was 9.85% during Q4 2021.
  • Over the past 5 years, Ptc Therapeutics' median Return on Equity value was 0.61% (recorded in 2024), while the average stood at 0.32%.
  • As far as peak fluctuations go, Ptc Therapeutics' Return on Equity soared by 130100bps in 2022, and later crashed by -102800bps in 2023.
  • Quarter analysis of 5 years shows Ptc Therapeutics' Return on Equity stood at 9.85% in 2021, then surged by 120bps to 1.96% in 2022, then plummeted by -51bps to 0.96% in 2023, then crashed by -39bps to 0.58% in 2024, then tumbled by -565bps to 2.7% in 2025.
  • Its last three reported values are 2.7% in Q3 2025, 1.87% for Q2 2025, and 0.52% during Q1 2025.